HEADER ISOMERASE/ISOMERASE INHIBITOR 09-SEP-16 5T9U TITLE DISCOVERY OF A POTENT CYCLOPHILIN INHIBITOR (COMPOUND 3) BASED ON TITLE 2 STRUCTURAL SIMPLIFICATION OF SANGLIFEHRIN A COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: PPIASE A,CYCLOPHILIN A,CYCLOSPORIN A-BINDING PROTEIN, COMPND 5 ROTAMASE A; COMPND 6 EC: 5.2.1.8; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPIA, CYPA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CYCLOPHILIN INHIBITOR ANTIVIRAL HCV, ISOMERASE-ISOMERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.C.APPLEBY,V.STEADMAN,S.PETTIT,U.SCHMITZ,R.L.MACKMAN,B.SCHULTZ REVDAT 6 06-MAR-24 5T9U 1 REMARK REVDAT 5 29-MAR-17 5T9U 1 TITLE REVDAT 4 15-FEB-17 5T9U 1 JRNL REVDAT 3 08-FEB-17 5T9U 1 JRNL REVDAT 2 01-FEB-17 5T9U 1 REMARK REVDAT 1 25-JAN-17 5T9U 0 JRNL AUTH V.A.STEADMAN,S.B.PETTIT,K.G.POULLENNEC,L.LAZARIDES, JRNL AUTH 2 A.J.KEATS,D.K.DEAN,S.J.STANWAY,C.A.AUSTIN,J.A.SANVOISIN, JRNL AUTH 3 G.M.WATT,H.G.FLIRI,A.C.LICLICAN,D.JIN,M.H.WONG,S.A.LEAVITT, JRNL AUTH 4 Y.J.LEE,Y.TIAN,C.R.FREY,T.C.APPLEBY,U.SCHMITZ,P.JANSA, JRNL AUTH 5 R.L.MACKMAN,B.E.SCHULTZ JRNL TITL DISCOVERY OF POTENT CYCLOPHILIN INHIBITORS BASED ON THE JRNL TITL 2 STRUCTURAL SIMPLIFICATION OF SANGLIFEHRIN A. JRNL REF J. MED. CHEM. V. 60 1000 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28075591 JRNL DOI 10.1021/ACS.JMEDCHEM.6B01329 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.16 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 61531 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.193 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.210 REMARK 3 FREE R VALUE TEST SET COUNT : 1978 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.1709 - 5.5427 0.99 4429 146 0.1587 0.1574 REMARK 3 2 5.5427 - 4.4006 1.00 4341 144 0.1233 0.1402 REMARK 3 3 4.4006 - 3.8447 1.00 4275 144 0.1277 0.1617 REMARK 3 4 3.8447 - 3.4933 1.00 4269 142 0.1501 0.1688 REMARK 3 5 3.4933 - 3.2430 1.00 4256 139 0.1601 0.2123 REMARK 3 6 3.2430 - 3.0519 1.00 4224 140 0.1865 0.2141 REMARK 3 7 3.0519 - 2.8990 1.00 4247 141 0.1953 0.2048 REMARK 3 8 2.8990 - 2.7729 1.00 4232 139 0.1878 0.2026 REMARK 3 9 2.7729 - 2.6661 1.00 4226 142 0.1951 0.2523 REMARK 3 10 2.6661 - 2.5741 1.00 4232 143 0.2015 0.2645 REMARK 3 11 2.5741 - 2.4937 1.00 4213 139 0.1925 0.2147 REMARK 3 12 2.4937 - 2.4224 1.00 4184 140 0.2070 0.2436 REMARK 3 13 2.4224 - 2.3586 1.00 4262 141 0.2176 0.2670 REMARK 3 14 2.3586 - 2.3011 0.99 4163 138 0.2168 0.2522 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.430 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 5360 REMARK 3 ANGLE : 1.146 7202 REMARK 3 CHIRALITY : 0.048 741 REMARK 3 PLANARITY : 0.005 937 REMARK 3 DIHEDRAL : 12.688 1876 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5T9U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-SEP-16. REMARK 100 THE DEPOSITION ID IS D_1000223945. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : D*TREK 9.7 W8RSSI REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61531 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 45.162 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.490 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.13 REMARK 200 R MERGE FOR SHELL (I) : 0.44500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 74.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS-HCL, PH 8.5 0.1 M POTASSIUM REMARK 280 CHLORIDE 2.2 M AMMONIUM SULFATE, VAPOR DIFFUSION, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 83.85733 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 41.92867 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 41.92867 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 83.85733 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 465 MET C 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 436 O HOH A 551 1.81 REMARK 500 O LEU D 164 O HOH D 401 1.93 REMARK 500 O HOH A 545 O HOH A 548 1.98 REMARK 500 O HOH A 521 O HOH A 547 1.98 REMARK 500 O HOH A 564 O HOH A 569 2.02 REMARK 500 O HOH A 483 O HOH A 553 2.02 REMARK 500 O HOH C 515 O HOH C 519 2.04 REMARK 500 O HOH C 462 O HOH C 502 2.04 REMARK 500 O HOH C 500 O HOH C 534 2.07 REMARK 500 O HOH D 522 O HOH D 526 2.07 REMARK 500 O HOH D 518 O HOH D 529 2.10 REMARK 500 O HOH B 511 O HOH B 525 2.11 REMARK 500 O HOH D 411 O HOH D 561 2.13 REMARK 500 OE2 GLU C 84 O HOH C 401 2.16 REMARK 500 O HOH B 513 O HOH B 517 2.17 REMARK 500 O HOH B 425 O HOH B 503 2.18 REMARK 500 O HOH D 459 O HOH D 557 2.19 REMARK 500 O HOH A 524 O HOH A 542 2.19 REMARK 500 O HOH C 520 O HOH C 533 2.19 REMARK 500 O HOH C 463 O HOH C 531 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 520 O HOH C 490 2654 1.86 REMARK 500 O HOH A 463 O HOH D 546 5666 2.13 REMARK 500 O HOH C 505 O HOH D 543 3665 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 60 -73.86 -116.47 REMARK 500 PHE C 60 -69.39 -121.19 REMARK 500 LYS C 133 -67.36 -90.36 REMARK 500 PHE D 60 -65.45 -122.63 REMARK 500 GLU D 81 -54.96 102.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 545 DISTANCE = 6.86 ANGSTROMS REMARK 525 HOH B 546 DISTANCE = 7.78 ANGSTROMS REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: 3-[(3-HYDROXYPHENYL)METHYL]-10,12-DIMETHOXY-9,11- REMARK 630 DIMETHYL-6-(PROPAN-2-YL)-19-OXA-1,4,7,25-TETRAAZABICYCLO[19.3.1] REMARK 630 PENTACOSA-13,15-DIENE-2,5,8,20-TETRONE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 7HG A 300 REMARK 630 7HG B 300 REMARK 630 7HG C 300 REMARK 630 7HG D 300 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 78F VAL MTY REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for REMARK 800 (3S,6S,9R,10R,11S,12S,13E,15E,21S)-3-[(3-hydroxyphenyl)methyl]- REMARK 800 10,12-dimethoxy-9,11-dimethyl-6-(propan-2-yl)-19-oxa-1,4,7,25- REMARK 800 tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone REMARK 800 chain A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for REMARK 800 (3S,6S,9R,10R,11S,12S,13E,15E,21S)-3-[(3-hydroxyphenyl)methyl]- REMARK 800 10,12-dimethoxy-9,11-dimethyl-6-(propan-2-yl)-19-oxa-1,4,7,25- REMARK 800 tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone REMARK 800 chain B REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for REMARK 800 (3S,6S,9R,10R,11S,12S,13E,15E,21S)-3-[(3-hydroxyphenyl)methyl]- REMARK 800 10,12-dimethoxy-9,11-dimethyl-6-(propan-2-yl)-19-oxa-1,4,7,25- REMARK 800 tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone REMARK 800 chain C REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for REMARK 800 (3S,6S,9R,10R,11S,12S,13E,15E,21S)-3-[(3-hydroxyphenyl)methyl]- REMARK 800 10,12-dimethoxy-9,11-dimethyl-6-(propan-2-yl)-19-oxa-1,4,7,25- REMARK 800 tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone REMARK 800 chain D REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5TA4 RELATED DB: PDB REMARK 900 RELATED ID: 5TA2 RELATED DB: PDB REMARK 900 RELATED ID: 5T9Z RELATED DB: PDB REMARK 900 RELATED ID: 5T9W RELATED DB: PDB DBREF 5T9U A 1 164 UNP P62937 PPIA_HUMAN 1 164 DBREF 5T9U B 1 164 UNP P62937 PPIA_HUMAN 1 164 DBREF 5T9U C 1 164 UNP P62937 PPIA_HUMAN 1 164 DBREF 5T9U D 1 164 UNP P62937 PPIA_HUMAN 1 164 SEQRES 1 A 164 MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL ASP SEQRES 2 A 164 GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE ALA SEQRES 3 A 164 ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 A 164 SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER CYS SEQRES 5 A 164 PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY GLY SEQRES 6 A 164 ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 A 164 TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU LYS SEQRES 8 A 164 HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA GLY SEQRES 9 A 164 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ALA SEQRES 10 A 164 LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 A 164 LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET GLU SEQRES 12 A 164 ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS ILE SEQRES 13 A 164 THR ILE ALA ASP CYS GLY GLN LEU SEQRES 1 B 164 MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL ASP SEQRES 2 B 164 GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE ALA SEQRES 3 B 164 ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 B 164 SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER CYS SEQRES 5 B 164 PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY GLY SEQRES 6 B 164 ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 B 164 TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU LYS SEQRES 8 B 164 HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA GLY SEQRES 9 B 164 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ALA SEQRES 10 B 164 LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 B 164 LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET GLU SEQRES 12 B 164 ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS ILE SEQRES 13 B 164 THR ILE ALA ASP CYS GLY GLN LEU SEQRES 1 C 164 MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL ASP SEQRES 2 C 164 GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE ALA SEQRES 3 C 164 ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 C 164 SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER CYS SEQRES 5 C 164 PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY GLY SEQRES 6 C 164 ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 C 164 TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU LYS SEQRES 8 C 164 HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA GLY SEQRES 9 C 164 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ALA SEQRES 10 C 164 LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 C 164 LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET GLU SEQRES 12 C 164 ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS ILE SEQRES 13 C 164 THR ILE ALA ASP CYS GLY GLN LEU SEQRES 1 D 164 MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL ASP SEQRES 2 D 164 GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE ALA SEQRES 3 D 164 ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 D 164 SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER CYS SEQRES 5 D 164 PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY GLY SEQRES 6 D 164 ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 D 164 TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU LYS SEQRES 8 D 164 HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA GLY SEQRES 9 D 164 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ALA SEQRES 10 D 164 LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 D 164 LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET GLU SEQRES 12 D 164 ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS ILE SEQRES 13 D 164 THR ILE ALA ASP CYS GLY GLN LEU HET 7HG A 300 46 HET 7HG B 300 46 HET 7HG C 300 46 HET 7HG D 300 46 HETNAM 7HG 3-[(3-HYDROXYPHENYL)METHYL]-10,12-DIMETHOXY-9,11- HETNAM 2 7HG DIMETHYL-6-(PROPAN-2-YL)-19-OXA-1,4,7,25- HETNAM 3 7HG TETRAAZABICYCLO[19.3.1]PENTACOSA-13,15-DIENE-2,5,8,20- HETNAM 4 7HG TETRONE FORMUL 5 7HG 4(C34 H50 N4 O8) FORMUL 9 HOH *628(H2 O) HELIX 1 AA1 VAL A 29 GLY A 42 1 14 HELIX 2 AA2 THR A 119 ASP A 123 5 5 HELIX 3 AA3 GLY A 135 ARG A 144 1 10 HELIX 4 AA4 VAL B 29 GLY B 42 1 14 HELIX 5 AA5 THR B 119 ASP B 123 5 5 HELIX 6 AA6 GLY B 135 ARG B 144 1 10 HELIX 7 AA7 VAL C 29 GLY C 42 1 14 HELIX 8 AA8 THR C 119 ASP C 123 5 5 HELIX 9 AA9 GLY C 135 ARG C 144 1 10 HELIX 10 AB1 VAL D 29 GLY D 42 1 14 HELIX 11 AB2 THR D 119 ASP D 123 5 5 HELIX 12 AB3 GLY D 135 ARG D 144 1 10 SHEET 1 AA1 8 PHE A 53 ILE A 57 0 SHEET 2 AA1 8 MET A 61 GLY A 64 -1 O MET A 61 N ILE A 57 SHEET 3 AA1 8 PHE A 112 CYS A 115 -1 O ILE A 114 N CYS A 62 SHEET 4 AA1 8 ILE A 97 MET A 100 -1 N SER A 99 O PHE A 113 SHEET 5 AA1 8 VAL A 128 GLU A 134 -1 O GLY A 130 N LEU A 98 SHEET 6 AA1 8 GLU A 15 LEU A 24 -1 N SER A 21 O LYS A 133 SHEET 7 AA1 8 THR A 5 VAL A 12 -1 N PHE A 8 O VAL A 20 SHEET 8 AA1 8 ILE A 156 GLN A 163 -1 O ASP A 160 N ASP A 9 SHEET 1 AA2 8 PHE B 53 ILE B 57 0 SHEET 2 AA2 8 MET B 61 GLY B 64 -1 O GLN B 63 N ARG B 55 SHEET 3 AA2 8 PHE B 112 CYS B 115 -1 O ILE B 114 N CYS B 62 SHEET 4 AA2 8 ILE B 97 MET B 100 -1 N ILE B 97 O CYS B 115 SHEET 5 AA2 8 VAL B 128 GLU B 134 -1 O GLY B 130 N LEU B 98 SHEET 6 AA2 8 GLU B 15 LEU B 24 -1 N SER B 21 O LYS B 133 SHEET 7 AA2 8 THR B 5 VAL B 12 -1 N ILE B 10 O GLY B 18 SHEET 8 AA2 8 ILE B 156 GLN B 163 -1 O ASP B 160 N ASP B 9 SHEET 1 AA3 8 ARG C 55 ILE C 57 0 SHEET 2 AA3 8 MET C 61 GLY C 64 -1 O GLN C 63 N ARG C 55 SHEET 3 AA3 8 PHE C 112 CYS C 115 -1 O ILE C 114 N CYS C 62 SHEET 4 AA3 8 ILE C 97 MET C 100 -1 N SER C 99 O PHE C 113 SHEET 5 AA3 8 VAL C 128 VAL C 132 -1 O GLY C 130 N LEU C 98 SHEET 6 AA3 8 GLU C 15 LEU C 24 -1 N GLU C 23 O LYS C 131 SHEET 7 AA3 8 THR C 5 VAL C 12 -1 N ILE C 10 O GLY C 18 SHEET 8 AA3 8 ILE C 156 GLN C 163 -1 O ASP C 160 N ASP C 9 SHEET 1 AA4 8 PHE D 53 ILE D 57 0 SHEET 2 AA4 8 MET D 61 GLY D 64 -1 O GLN D 63 N ARG D 55 SHEET 3 AA4 8 PHE D 112 CYS D 115 -1 O ILE D 114 N CYS D 62 SHEET 4 AA4 8 ILE D 97 MET D 100 -1 N SER D 99 O PHE D 113 SHEET 5 AA4 8 VAL D 128 GLU D 134 -1 O GLY D 130 N LEU D 98 SHEET 6 AA4 8 GLU D 15 LEU D 24 -1 N SER D 21 O LYS D 133 SHEET 7 AA4 8 THR D 5 VAL D 12 -1 N ILE D 10 O LEU D 17 SHEET 8 AA4 8 ILE D 156 GLN D 163 -1 O ASP D 160 N ASP D 9 SITE 1 AC1 16 ARG A 55 MET A 61 GLN A 63 THR A 73 SITE 2 AC1 16 ALA A 101 ASN A 102 ALA A 103 GLN A 111 SITE 3 AC1 16 PHE A 113 LEU A 122 HIS A 126 HOH A 401 SITE 4 AC1 16 HOH A 408 TRP B 121 LYS B 125 7HG B 300 SITE 1 AC2 17 TRP A 121 7HG A 300 ARG B 55 MET B 61 SITE 2 AC2 17 GLN B 63 GLY B 72 THR B 73 ALA B 101 SITE 3 AC2 17 ASN B 102 ALA B 103 GLN B 111 PHE B 113 SITE 4 AC2 17 LEU B 122 HIS B 126 HOH B 404 HOH B 412 SITE 5 AC2 17 HOH B 431 SITE 1 AC3 14 ARG C 55 MET C 61 GLN C 63 ALA C 101 SITE 2 AC3 14 ASN C 102 ALA C 103 GLN C 111 PHE C 113 SITE 3 AC3 14 LEU C 122 HIS C 126 HOH C 413 TRP D 121 SITE 4 AC3 14 7HG D 300 HOH D 467 SITE 1 AC4 16 TRP C 121 7HG C 300 ARG D 55 MET D 61 SITE 2 AC4 16 GLN D 63 GLY D 72 THR D 73 ALA D 101 SITE 3 AC4 16 ASN D 102 ALA D 103 GLN D 111 PHE D 113 SITE 4 AC4 16 LEU D 122 HIS D 126 HOH D 412 HOH D 423 CRYST1 137.973 137.973 125.786 90.00 90.00 120.00 P 32 2 1 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007248 0.004185 0.000000 0.00000 SCALE2 0.000000 0.008369 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007950 0.00000